Related Experiment Videos
Antifungal agents and their renal implications in the neonate
Abstract:
The incidence of superficial or systemic fungal infections has been increasing in neonates. The cause of this increased susceptibility to fungal infections is due to the increased use of mechanical ventilation, indwelling catheters, broad-spectrum antibiotic therapy, parenteral nutrition, and steroid therapy. The most common organism encountered in neonatal infections is Candida species. This article will cover the etiology, signs, symptoms, diagnosis, and treatment of the usual neonatal fungal infections. Each of the antifungal agents used to treat neonates will be discussed with regard to its mechanism of action, pharmacokinetics, indications, normal and renal functional impairment dosing, and adverse effects.
Insights
Neonatal fungal infections are rising due to medical interventions. This review covers causes, symptoms, diagnosis, and treatments for Candida infections in newborns.
Area of Science:
- Neonatology
- Infectious Diseases
- Mycology
Background:
- Increasing incidence of superficial and systemic fungal infections in neonates.
- Susceptibility linked to mechanical ventilation, indwelling catheters, broad-spectrum antibiotics, parenteral nutrition, and steroid therapy.
- Candida species are the most common causative organisms in neonatal fungal infections.
Purpose of the Study:
- To provide a comprehensive overview of neonatal fungal infections.
- To detail the etiology, clinical presentation, diagnosis, and management strategies.
- To review antifungal agents used in neonates, including mechanism of action, pharmacokinetics, dosing, and adverse effects.
Main Methods:
- Literature review of neonatal fungal infections.
- Synthesis of information on causative agents, risk factors, and clinical manifestations.
- Analysis of diagnostic approaches and treatment guidelines for antifungal therapies.
Main Results:
- Fungal infections in neonates are increasingly prevalent.
- Specific medical practices contribute to heightened susceptibility.
- Candida species represent the predominant pathogens.
Conclusions:
- Effective management of neonatal fungal infections requires understanding their etiology and risk factors.
- Appropriate diagnosis and timely administration of antifungal agents are crucial.
- Knowledge of antifungal pharmacokinetics and safety profiles is essential for optimal neonatal care.